The current price of XLO is $8.62 — it has increased by 1.41% since the previous close. Data as of Nov 6, 2026.
XLO is up 15.09% over the past week, down 4.33% over the past month and down 23.72% over the past year. The price is above its 200-day moving average of $8.49.
Xilio Therapeutics, Inc. has a market capitalization of $56.72M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Xilio Therapeutics, Inc. posted a loss of $0.33 per share against an estimate of -$0.59, beating expectations by 44.07%. Upcoming reports are listed in the earnings calendar.
Xilio Therapeutics, Inc. reported revenue of $18.69M in its most recent quarter, which has increased by 131.05% compared with the same quarter a year earlier. Analysts had expected $12.72M.
In the latest trading session XLO moved between $8.24 and $8.72, a range of 5.51% of its current price.
Over the past 52 weeks XLO has traded between $6.47 and $11.75. The current price is 26.64% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.